Evidence map›Paper›PMID 27532670›Full record

ArticleJournal of the American Chemical Society2016

A Helping Hand to Overcome Solubility Challenges in Chemical Protein Synthesis.

Michael T Jacobsen, Mark E Petersen, Xiang Ye, Mathieu Galibert, George H Lorimer, Vincent Aucagne, Michael S Kay

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  2. Article
  3. Article
  4. BracketMaker: Visualization and optimization of chemical protein synthesis.Protein science : a publication of the Protein Society · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Total synthesis of interleukin-2Chemical science · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael T JacobsenDepartment of Biochemistry, University of Utah School of Medicine , 15 North Medical Drive East, Room 4100, Salt Lake City, Utah 84112-5650, United States.
Mark E PetersenDepartment of Biochemistry, University of Utah School of Medicine , 15 North Medical Drive East, Room 4100, Salt Lake City, Utah 84112-5650, United States.
Xiang YeDepartment of Chemistry & Biochemistry, 8051 Regents Drive, University of Maryland , College Park, Maryland 20742-4454, United States.
Mathieu GalibertCentre de Biophysique Moléculaire, CNRS UPR4301 , Rue Charles Sadron, Orléans CEDEX 2 45071, France.
George H LorimerDepartment of Chemistry & Biochemistry, 8051 Regents Drive, University of Maryland , College Park, Maryland 20742-4454, United States.
Vincent AucagneCentre de Biophysique Moléculaire, CNRS UPR4301 , Rue Charles Sadron, Orléans CEDEX 2 45071, France.
Michael S KayDepartment of Biochemistry, University of Utah School of Medicine , 15 North Medical Drive East, Room 4100, Salt Lake City, Utah 84112-5650, United States.

Funding

TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
D-peptide Inhibitors of HIV-1 EntryR01AI076168 · NIAID · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2008 to 2017
$3.1M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR44AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2015 to 2017
$2.9M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR43AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2012 to 2013
$600k
D-peptide Inhibitors of HIV-1 EntryR56AI076168 · NIAID · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2012 to 2012
$374k
Characterization and Development of a Coiled-Coil to Treat Non-Hodgkin LymphomaF31CA171677 · NCI · UNIVERSITY OF UTAH · PI JACOBSEN, MICHAEL · 2012 to 2013
$84k
NCI NIH HHS F31 CA171677NHLBI NIH HHS T32 HL007576NIAID NIH HHS R01 AI076168NIAID NIH HHS R43 AI102347NIAID NIH HHS R44 AI102347NIAID NIH HHS R56 AI076168
6 · The paper itself

Abstract

Although native chemical ligation (NCL) and related chemoselective ligation approaches provide an elegant method to stitch together unprotected peptides, the handling and purification of insoluble and aggregation-prone peptides and assembly intermediates create a bottleneck to routinely preparing large proteins by completely synthetic means. In this work, we introduce a new general tool, Fmoc-Ddae-OH, N-Fmoc-1-(4,4-dimethyl-2,6-dioxocyclo-hexylidene)-3-[2-(2-aminoethoxy)ethoxy]-propan-1-ol, a heterobifunctional traceless linker for temporarily attaching highly solubilizing peptide sequences ("helping hands") onto insoluble peptides. This tool is implemented in three simple and nearly quantitative steps: (i) on-resin incorporation of the linker at a Lys residue ε-amine, (ii) Fmoc-SPPS elongation of a desired solubilizing sequence, and (iii) in-solution removal of the solubilizing sequence using mild aqueous hydrazine to cleave the Ddae linker after NCL-based assembly. Successful introduction and removal of a Lys6 helping hand is first demonstrated in two model systems (Ebola virus C20 peptide and the 70-residue ribosomal protein L31). It is then applied to the challenging chemical synthesis of the 97-residue co-chaperonin GroES, which contains a highly insoluble C-terminal segment that is rescued by a helping hand. Importantly, the Ddae linker can be cleaved in one pot following NCL or desulfurization. The purity, structure, and chaperone activity of synthetic l-GroES were validated with respect to a recombinant control. Additionally, the helping hand enabled synthesis of d-GroES, which was inactive in a heterochiral mixture with recombinant GroEL, providing additional insight into chaperone specificity. Ultimately, this simple, robust, and easy-to-use tool is expected to be broadly applicable for the synthesis of challenging peptides and proteins.

Indexed as

Amino Acid SequenceChemistry Techniques, SyntheticFluorenesProtein FoldingProteinsRibosomal ProteinsSolubilityViral Proteins9-fluorenylmethoxycarbonylFluorenesProteinsribosomal protein L31Ribosomal ProteinsViral Proteins

Identifiers

PMID27532670
PMCPMC5094862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.